MediPharm Labs Corp.

TSX:LABS Rapporto sulle azioni

Cap. di mercato: CA$28.8m

MediPharm Labs Gestione

Gestione criteri di controllo 3/4

MediPharm Labs Il CEO è David Pidduck, nominato in Apr2022, e ha un mandato di 2.58 anni. la retribuzione annua totale è CA$ 1.31M, composta da 36% di stipendio e 64% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 4.08% delle azioni della società, per un valore di CA$ 1.17M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.1 anni e 5.4 anni.

Informazioni chiave

David Pidduck

Amministratore delegato

CA$1.3m

Compenso totale

Percentuale dello stipendio del CEO36.0%
Mandato del CEO2.6yrs
Proprietà del CEO4.1%
Durata media del management5.1yrs
Durata media del Consiglio di amministrazione5.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

MediPharm Labs Corp. (TSE:LABS) Doing What It Can To Lift Shares

Oct 11
MediPharm Labs Corp. (TSE:LABS) Doing What It Can To Lift Shares

MediPharm Labs (TSE:LABS) Is Using Debt Safely

May 29
MediPharm Labs (TSE:LABS) Is Using Debt Safely

Market Might Still Lack Some Conviction On MediPharm Labs Corp. (TSE:LABS) Even After 31% Share Price Boost

Mar 23
Market Might Still Lack Some Conviction On MediPharm Labs Corp. (TSE:LABS) Even After 31% Share Price Boost

Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?

Jan 10
Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?

MediPharm Labs (TSE:LABS) Has Debt But No Earnings; Should You Worry?

Sep 06
MediPharm Labs (TSE:LABS) Has Debt But No Earnings; Should You Worry?

MediPharm Labs Corp. (TSE:LABS) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 17
MediPharm Labs Corp. (TSE:LABS) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook

Aug 20
Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook

Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) Estimates

May 21
Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) Estimates

Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's Downgrade

Apr 06
Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's Downgrade

Is MediPharm Labs (TSE:LABS) Using Too Much Debt?

Mar 07
Is MediPharm Labs (TSE:LABS) Using Too Much Debt?

Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?

Aug 18
Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?

Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's Estimates

May 23
Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's Estimates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di David Pidduck rispetto agli utili di MediPharm Labs?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-CA$12m

Jun 30 2024n/an/a

-CA$13m

Mar 31 2024n/an/a

-CA$14m

Dec 31 2023CA$1mCA$470k

-CA$13m

Sep 30 2023n/an/a

-CA$16m

Jun 30 2023n/an/a

-CA$20m

Mar 31 2023n/an/a

-CA$26m

Dec 31 2022CA$3mCA$315k

-CA$30m

Compensazione vs Mercato: La retribuzione totale di David ($USD 934.30K ) è superiore alla media delle aziende di dimensioni simili nel mercato Canadian ($USD 169.25K ).

Compensazione vs guadagni: La retribuzione di David è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

David Pidduck

2.6yrs

Mandato

CA$1,305,051

Compensazione

Mr. David A. Pidduck is Chief Executive Officer and Director at MediPharm Labs Corp. since April 20, 2022. Mr. Pidduck has been the Chief Executive Officer and President of Purdue Pharma Inc. since Septemb...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
David Pidduck
CEO & Director2.6yrsCA$1.31m4.08%
CA$ 1.2m
Keith Strachan
Co-Founder & President5.8yrsCA$819.48k2.17%
CA$ 624.2k
Greg Hunter
Chief Financial Officer3.8yrsCA$957.75k0.31%
CA$ 90.5k
Patrick McCutcheon
Founder9.8yrsCA$858.16kNessun dato
Brett Moon
Vice President of Sales4.5yrsNessun datoNessun dato
Kirk Binns
Executive Vice President of Global Accounts5.8yrsNessun datoNessun dato

5.1yrs

Durata media

Gestione esperta: Il team dirigenziale di LABS è esperto e expertise (durata media dell'incarico 5.1 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
David Pidduck
CEO & Director2.6yrsCA$1.31m4.08%
CA$ 1.2m
Shelley Martin
Independent Director4.4yrsCA$64.49k0.020%
CA$ 5.6k
Michael Bumby
Independent Director1.6yrsCA$34.45k0.050%
CA$ 14.4k
Christopher Taves
Independent Chairman of the Board4.3yrsCA$87.14k0.35%
CA$ 99.6k
Miriam McDonald
Member of the Science Advisory Board5.6yrsCA$32.40kNessun dato
Leslie Brown
Member of the Science Advisory Board5.6yrsNessun datoNessun dato
Matt Archibald
Member of the Science Advisory Board5.6yrsNessun datoNessun dato
Markus Roggen
Member of the Science Advisory Board5.6yrsNessun datoNessun dato
Arshad Hack
Member of the Science Advisory Board5.6yrsNessun datoNessun dato
Jerry King
Member of the Science Advisory Board5.6yrsNessun datoNessun dato
Carolina Landolt-Marticorena
Member of the Science Advisory Board5.3yrsNessun datoNessun dato
Christopher Halyk
Independent Director4.3yrsCA$56.05k0.043%
CA$ 12.3k

5.4yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di LABS sono considerati esperti (durata media dell'incarico 5.4 anni).